Eisai Certified as a 2023 Health and Productivity Management Outstanding
TOKYO, Mar 9, 2023 – (JCN Newswire) – Eisai Co., Ltd. announced today that it…
TOKYO, Mar 9, 2023 – (JCN Newswire) – Eisai Co., Ltd. announced today that it…
EVANSVILLE, Ind.–(BUSINESS WIRE)–Berry Global Group, Inc. (NYSE: BERY) (“Berry”), a leading supplier of packaging solutions…
BUENOS AIRES–(BUSINESS WIRE)–Loma Negra, (NYSE: LOMA; BYMA: LOMA), (“Loma Negra” or the “Company”), the leading…
ROCKVILLE, MD, March 08, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company…
Quoin announced dosing of first patient in double blinded clinical study to evaluate QRX003 for…
TORONTO, Ontario and CAMBRIDGE, Massachusetts, March 08, 2023 (GLOBE NEWSWIRE) — Completed all preclinical studies…
– Nirogacestat Treatment Significantly Improved Progression-Free Survival, Objective Response Rate and Key Patient Reported Outcomes…
NEWS RELEASE – REGULATED INFORMATIONMARCH 8, 2023, 5:00 pm ET/ 23:00 CET IRVINE, CA, and…
SEATTLE, March 08, 2023 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…
NEW YORK & SINGAPORE & HONG KONG–(BUSINESS WIRE)–Dr. Calvin Choi, chairman of AMTD Group and…
TORONTO and CHICAGO, March 08, 2023 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals (TSX: MDP; TSX: MDP.DB; OTCQX: MEDXF) today…
Entered into a €40 million credit facility with the European Investment Bank and closed an…
Full-Year Net Revenue of $10 Million and Fourth Quarter Net Revenue of $2.6 Million SOUTH…
Webcast set for 7:30 a.m. ET on March 9 SALT LAKE CITY, March 08, 2023…
Announced Expansion of Briquilimab (formerly known as JSP191) Development Strategy to Include Chronic Spontaneous Urticaria…
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., March 08, 2023…
SAN FRANCISCO, March 08, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
ROCKVILLE, Md., March 08, 2023 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical…
SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) — Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision…
SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical…